Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.920
+0.010 (0.34%)
At close: Apr 27, 2026, 4:00 PM EDT
2.920
0.00 (0.00%)
After-hours: Apr 27, 2026, 4:10 PM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.95 million as of April 27, 2026. Its market cap has decreased by -59.03% in one year.
Market Cap
6.95M
Enterprise Value
-2.09M
1-Year Change
-59.03%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.95M, a decrease of -62.41%. That is a compound annual growth rate of -5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 6.95M | -71.79% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 7.63M |
| Indaptus Therapeutics | 7.40M |
| Addex Therapeutics | 7.39M |
| Aptorum Group | 7.31M |
| Acurx Pharmaceuticals | 7.27M |
| Immuron | 7.23M |
| Xenetic Biosciences | 7.14M |
| Alaunos Therapeutics | 6.56M |